BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9178945)

  • 1. Development of a membrane fusible drug carrier from erythrocytes by the spontaneous transfer of viral fusion protein from influenza virus-infected cells.
    Kogure K; Okuda O; Itoh T; Hayashi K; Ueno M
    Biol Pharm Bull; 1997 May; 20(5):581-3. PubMed ID: 9178945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore.
    Kozerski C; Ponimaskin E; Schroth-Diez B; Schmidt MF; Herrmann A
    J Virol; 2000 Aug; 74(16):7529-37. PubMed ID: 10906206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane fusion by single influenza hemagglutinin trimers. Kinetic evidence from image analysis of hemagglutinin-reconstituted vesicles.
    Imai M; Mizuno T; Kawasaki K
    J Biol Chem; 2006 May; 281(18):12729-35. PubMed ID: 16505474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class II fusion protein of alphaviruses drives membrane fusion through the same pathway as class I proteins.
    Zaitseva E; Mittal A; Griffin DE; Chernomordik LV
    J Cell Biol; 2005 Apr; 169(1):167-77. PubMed ID: 15809312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of substitution of hemagglutinin-neuraminidase with influenza hemagglutinin on Sendai virus F protein mediated membrane fusion.
    Bagai S; Sarkar DP
    FEBS Lett; 1994 Oct; 353(3):332-6. PubMed ID: 7957887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
    Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein.
    Ali A; Avalos RT; Ponimaskin E; Nayak DP
    J Virol; 2000 Sep; 74(18):8709-19. PubMed ID: 10954572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemifusion activity of a chimeric influenza virus hemagglutinin with a putative fusion peptide from hepatitis B virus.
    Berting A; Fischer C; Schaefer S; Garten W; Klenk HD; Gerlich WH
    Virus Res; 2000 Jun; 68(1):35-49. PubMed ID: 10930661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the fusion peptide sequence in initial stages of influenza hemagglutinin-induced cell fusion.
    Schoch C; Blumenthal R
    J Biol Chem; 1993 May; 268(13):9267-74. PubMed ID: 8387488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmitoylation Contributes to Membrane Curvature in Influenza A Virus Assembly and Hemagglutinin-Mediated Membrane Fusion.
    Chlanda P; Mekhedov E; Waters H; Sodt A; Schwartz C; Nair V; Blank PS; Zimmerberg J
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion activity of the influenza virus hemagglutinin does not require a transbilayer pH gradient.
    Ramalho-Santos J; de Lima MC
    Biochim Biophys Acta; 1997 Dec; 1330(2):194-8. PubMed ID: 9408172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the Glu residues of the influenza hemagglutinin fusion peptide in the pH dependence of fusion activity.
    Korte T; Epand RF; Epand RM; Blumenthal R
    Virology; 2001 Oct; 289(2):353-61. PubMed ID: 11689057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of X31 influenza virus fusion on phosphatidylserine asymmetry in erythrocytes.
    Pak CC; Blumenthal R
    Biochim Biophys Acta; 1996 Jan; 1278(1):98-104. PubMed ID: 8611613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional specificity of Influenza virus haemagglutinin and paramyxovirus fusion protein anchoring peptides.
    Kordyukova L
    Virus Res; 2017 Jan; 227():183-199. PubMed ID: 27773768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion.
    Melikyan GB; Lin S; Roth MG; Cohen FS
    Mol Biol Cell; 1999 Jun; 10(6):1821-36. PubMed ID: 10359599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediates in influenza virus PR/8 haemagglutinin-induced membrane fusion.
    Pak CC; Krumbiegel M; Blumenthal R
    J Gen Virol; 1994 Feb; 75 ( Pt 2)():395-9. PubMed ID: 8113761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influenza virus-induced fusion of erythrocyte ghosts does not depend on osmotic forces.
    Herrmann A; Pritzen C; Palesch A; Groth T
    Biochim Biophys Acta; 1988 Sep; 943(3):411-8. PubMed ID: 3415984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tight binding of influenza virus hemagglutinin to its receptor interferes with fusion pore dilation.
    Ohuchi M; Ohuchi R; Sakai T; Matsumoto A
    J Virol; 2002 Dec; 76(24):12405-13. PubMed ID: 12438566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane fusion of mumps virus with ghost erythrocytes and CV-1 cells.
    Di Simone C; Baldeschwieler JD
    Virology; 1992 Nov; 191(1):338-45. PubMed ID: 1413510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype.
    Qiao H; Armstrong RT; Melikyan GB; Cohen FS; White JM
    Mol Biol Cell; 1999 Aug; 10(8):2759-69. PubMed ID: 10436026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.